Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
CAE Inc. Common Shares
CAE
$8.49B
| $44.5M | 0.02% |
1,443,963
-252,693
| -15% | -$7.73M |
|
602
Suncor Energy
SU
$75.5B
| $44.4M | 0.02% |
1,852,606
-126,312
| -6% | -$2.9M |
|
603
Privia Health
PRVA
$3.12B
| $44.2M | 0.02% |
+995,879
| New | +$36.7M |
|
604
Patria Investments
PAX
$1.76B
| $44M | 0.02% |
2,498,493
+7,079
| +0.3% | +$113K |
|
|
MSDAU
605
DELISTED
MSD Acquisition Corp. Unit
MSDAU
| $43.8M | 0.02% |
4,337,664
-162,336
| -4% | -$1.66M |
|
606
M&T Bank
MTB
$36.5B
| $43.8M | 0.02% |
301,459
-179,656
| -37% | -$28.1M |
|
|
WIRE
607
DELISTED
Encore Wire Corp
WIRE
| $43.7M | 0.02% |
576,522
-101,054
| -15% | -$7.78M |
|
608
Sotera Health
SHC
$5.01B
| $43.3M | 0.02% |
1,785,554
-307,372
| -15% | -$7.56M |
|
|
MDLA
609
DELISTED
Medallia, Inc.
MDLA
| $43M | 0.02% |
1,274,996
-36,624
| -3% | -$1.05M |
|
610
SPX Corp
SPXC
$10.3B
| $43M | 0.02% |
703,331
-33,312
| -5% | -$2.03M |
|
611
C4 Therapeutics
CCCC
$391M
| $42.9M | 0.02% |
1,133,129
-162,461
| -13% | -$5.82M |
|
|
QVCGA
612
DELISTED
QVC Group Inc Series A
QVCGA
| $42.8M | 0.02% |
65,396
+10,544
| +19% | +$6.77M |
|
|
HSKA
613
DELISTED
Heska Corp
HSKA
| $42.8M | 0.02% |
186,247
-4,957
| -3% | -$973K |
|
614
RLI Corp
RLI
$5.98B
| $42.7M | 0.02% |
816,044
-29,964
| -4% | -$1.63M |
|
615
BioAtla
BCAB
$5.69M
| $42.5M | 0.02% |
20,053
-595
| -3% | -$1.34M |
|
|
PXD
616
DELISTED
Pioneer Natural Resource Co.
PXD
| $42.4M | 0.02% |
261,077
-26,872
| -9% | -$4.22M |
|
617
FLEX LNG
FLNG
$1.68B
| $42.4M | 0.02% |
2,942,939
-492,039
| -14% | -$6.31M |
|
618
Ross Stores
ROST
$80.8B
| $41.9M | 0.02% |
338,198
-23,111
| -6% | -$2.88M |
|
619
FB Financial Corp
FBK
$2.98B
| $41.4M | 0.02% |
1,110,249
+14,730
| +1% | +$611K |
|
620
Martin Marietta Materials
MLM
$34.9B
| $41.4M | 0.02% |
117,758
-21,829
| -16% | -$7.78M |
|
621
Caterpillar
CAT
$386B
| $41.3M | 0.02% |
189,660
-25,284
| -12% | -$5.84M |
|
622
Oscar Health
OSCR
$9.43B
| $41M | 0.02% |
1,906,392
-215,156
| -10% | -$5.15M |
|
623
Intellia Therapeutics
NTLA
$1.52B
| $41M | 0.02% |
253,097
+217,437
| +610% | +$16.9M |
|
624
Alcon
ALC
$33.7B
| $40.5M | 0.02% |
577,601
+92,116
| +19% | +$6.56M |
|
|
ZY
625
DELISTED
Zymergen Inc. Common Stock
ZY
| $40.3M | 0.02% |
+1,006,941
| New | +$39.7M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.